Ubs Group Ag Sol Gel Technologies Ltd. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 3,459 shares of SLGL stock, worth $3,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,459

Holding current value

$3,839

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.37 - $0.96 $1,279 - $3,320	3,459 New	3,459 $2,000
Q1 2024 May 13, 2024	SELL	$0.95 - $1.5 $6,849 - $10,815	-7,210 Reduced 67.92%	3,405 $3,000
Q4 2023 Feb 09, 2024	BUY	$0.92 - $1.6 $9,765 - $16,984	10,615 New	10,615 $11,000
Q2 2023 Aug 11, 2023	BUY	$2.99 - $4.15 $1,369 - $1,900	458 New	458 $1,000
Q4 2022 Feb 08, 2023	BUY	$4.26 - $5.22 $12,707 - $15,571	2,983 New	2,983 $13,000
Q2 2022 Aug 10, 2022	SELL	$4.1 - $7.36 $2,689 - $4,828	-656 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.64 - $8.21 $5,810 - $7,183	-875 Reduced 57.15%	656 $5,000
Q4 2021 Feb 14, 2022	BUY	$6.57 - $9.78 $6,478 - $9,643	986 Added 180.92%	1,531 $11,000
Q3 2021 Nov 15, 2021	SELL	$8.85 - $12.5 $66,401 - $93,787	-7,503 Reduced 93.23%	545 $5,000
Q2 2021 Aug 13, 2021	BUY	$9.53 - $14.7 $74,858 - $115,468	7,855 Added 4069.95%	8,048 $100,000
Q1 2021 May 12, 2021	BUY	$8.75 - $15.49 $1,522 - $2,695	174 Added 915.79%	193 $2,000
Q4 2020 Feb 11, 2021	SELL	$7.11 - $9.99 $57,399 - $80,649	-8,073 Reduced 99.77%	19 $0
Q3 2020 Nov 12, 2020	BUY	$7.15 - $8.73 $45,874 - $56,011	6,416 Added 382.82%	8,092 $59,000
Q2 2020 Jul 31, 2020	BUY	$6.15 - $9.4 $8,517 - $13,019	1,385 Added 475.95%	1,676 $15,000
Q1 2020 May 01, 2020	SELL	$5.88 - $15.75 $4,168 - $11,166	-709 Reduced 70.9%	291 $2,000
Q4 2019 Feb 14, 2020	SELL	$7.5 - $17.15 $6,585 - $15,057	-878 Reduced 46.75%	1,000 $17,000
Q3 2019 Nov 14, 2019	SELL	$7.7 - $10.48 $1,478 - $2,012	-192 Reduced 9.28%	1,878 $17,000
Q2 2019 Aug 14, 2019	SELL	$6.78 - $9.49 $7,451 - $10,429	-1,099 Reduced 34.68%	2,070 $19,000
Q1 2019 May 14, 2019	BUY	$5.71 - $7.19 $5,710 - $7,190	1,000 Added 46.1%	3,169 $22,000
Q4 2018 Feb 14, 2019	SELL	$5.79 - $8.1 $7,474 - $10,457	-1,291 Reduced 37.31%	2,169 $13,000
Q3 2018 Nov 14, 2018	BUY	$6.2 - $7.8 $2,442 - $3,073	394 Added 12.85%	3,460 $26,000
Q2 2018 Aug 14, 2018	BUY	$7.5 - $10.71 $15,495 - $22,126	2,066 Added 206.6%	3,066 $24,000
Q1 2018 May 15, 2018	BUY	$10.3 - $13.64 $10,300 - $13,640	1,000 New	1,000 $10,000

Others Institutions Holding SLGL

# of Institutions

Shares Held

5.35M

Call Options Held

1.5K

Put Options Held

Phoenix Holdings Ltd. Givatayim, L3

2.47M
Shares

$2.74 Million
0.03% of portfolio
Migdal Insurance & Financial Holdings Ltd.

1.23M
Shares

$1.36 Million
0.01% of portfolio
Harel Insurance Investments & Financial Services Ltd.

920K
Shares

$1.02 Million
0.01% of portfolio
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3

229K
Shares

$254,387
0.03% of portfolio
Prosperity Wealth Management, Inc. San Ramon, CA

163K
Shares

$181,374
0.04% of portfolio

View Full List

About Sol-Gel Technologies Ltd.

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $25.7M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

More about SLGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account